Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alexey Medvedchikov"'
Autor:
Martin Prázný, Lyudmila Suplotova, Janusz Gumprecht, Zdravko Kamenov, Tibor Fülöp, Alexey Medvedchikov, Doron Rosenzweig, Milos Aleksandric
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-17 (2022)
Abstract Background Guidelines from 2016 onwards recommend early use of SGLT2i or GLP-1 RA for patients with type 2 diabetes (T2D) and cardiovascular disease (CVD), to reduce CV events and mortality. Many eligible patients are not treated accordingly
Externí odkaz:
https://doaj.org/article/df7c4cf2f24543638cbd7bffdc452ab4
Autor:
Dragos Vinereanu, Dmitry Napalkov, Jutta Bergler-Klein, Bela Benczur, Martin Ciernik, Nina Gotcheva, Alexey Medvedchikov, Pentti Põder, Dragan Simic, Andris Skride, Wenbo Tang, Maria Trusz-Gluza, Jiri Vesely, Tatiana Vishnepolsky, Mirej Vrabec
Publikováno v:
Open Heart, Vol 7, Iss 1 (2020)
ObjectiveWe evaluated atrial fibrillation (AF) patients’ perceptions of anticoagulation treatment with dabigatran or a vitamin K antagonist (VKA) for stroke prevention, according to accepted indications.MethodsThe RE-SONANCE observational, prospect
Externí odkaz:
https://doaj.org/article/4484b1c0f0c84bc18b2f3e07d4afe53f
Autor:
Martin Ciernik, Dragan Simic, Jiří Vesely, Andris Skride, Bela Benczur, Jutta Bergler-Klein, Dragos Vinereanu, Maria Trusz-Gluza, Wenbo Tang, Pentti Põder, Alexey Medvedchikov, Nina Gotcheva, Dmitry Napalkov
Publikováno v:
Journal of Thrombosis and Thrombolysis
Background The oral anticoagulant dabigatran offers an effective alternative to vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF), yet patient preference data are limited. The prospective observational RE-SONANCE study de
Autor:
Maria Sanzharovskaya, Jana Kociánová, Arschang Valipour, Monika Haaksma-Herczegh, Claudia Toma, Zvi G Fridlender, Jurij Sorli, Alexey Medvedchikov, Valentina Bayer, Michael Tamm, Bohumil Matula, Janos Mucsi, Andrey Belevskiy
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:2343-2354
Background Reduced physical activity is associated with increased morbidity and mortality in patients with COPD. Studies suggest that treatment with the long-acting muscarinic antagonist tiotropium and the long-acting β2-agonist olodaterol increases
Autor:
Marc Spielmanns, Maria Sanzharovskaya, Ramona Miron, Mariela Georgieva, Jurij Sorli, Valentina Bayer, Adam Barczyk, Ondřej Kudela, Zvi G Fridlender, Zsuzsanna Szalai, Alexey Medvedchikov, Virginija Šileikienė, Arschang Valipour, Sergey Avdeev
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
International journal of chronic obstructive pulmonary disease, Auckland : Dove Medical Press Ltd., 2021, vol. 16, p. 615-628
International journal of chronic obstructive pulmonary disease, Auckland : Dove Medical Press Ltd., 2021, vol. 16, p. 615-628
Arschang Valipour,1 Sergey Avdeev,2 Adam Barczyk,3 Valentina Bayer,4 Zvi Fridlender,5 Mariela Georgieva,6 OndÅej Kudela,7 Alexey Medvedchikov,8 Ramona Miron,9 Maria Sanzharovskaya,8 Virginija ŠileikienÄ,10 Jurij Šorli,11 Marc Spielmanns,12 Zs
Autor:
Sergey Avdeev, Virginija Šileikienė, Jurij Sorli, Ondřej Kudela, Mariela Georgieva, Ramona Miron, Arschang Valipour, Alexey Medvedchikov, Marc Spielmanns, Maria Sanzharovskaya, Zsuzsanna Szalai, Valentina Bayer, Zvi G. Fridlender, Adam Barczyk
Publikováno v:
Airway pharmacology and treatment.
Background: The Clinical COPD Questionnaire (CCQ) is a simple patient-reported tool to measure clinical control of COPD. Aim: This open-label, non-interventional study investigated changes in CCQ score during treatment with tiotropium/olodaterol (Tio
Autor:
Tatiana Vishnepolsky, Andris Skride, Dmitry Napalkov, Nina Gotcheva, Jutta Bergler-Klein, Alexey Medvedchikov, Wenbo Tang, Dragan Simic, Mirej Vrabec, Jiri Vesely, Pentti Põder, Maria Trusz-Gluza, Dragos Vinereanu, Bela Benczur, Martin Ciernik
Publikováno v:
Open Heart
Open Heart, Vol 7, Iss 1 (2020)
Open Heart, Vol 7, Iss 1 (2020)
ObjectiveWe evaluated atrial fibrillation (AF) patients’ perceptions of anticoagulation treatment with dabigatran or a vitamin K antagonist (VKA) for stroke prevention, according to accepted indications.MethodsThe RE-SONANCE observational, prospect
Autor:
A. Marseille, Valentina Bayer, Arschang Valipour, Christoph M. Zehendner, Alexey Medvedchikov, M. Haaksma-Herczegh, Christian Taube, Anke Kondla
Publikováno v:
B45. COPD: TREATMENT.
Autor:
Arschang, Valipour, Michael, Tamm, Jana, Kociánová, Valentina, Bayer, Maria, Sanzharovskaya, Alexey, Medvedchikov, Monika, Haaksma-Herczegh, János, Mucsi, Zvi, Fridlender, Claudia, Toma, Andrey, Belevskiy, Bohumil, Matula, Jurij, Šorli
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Background Reduced physical activity is associated with increased morbidity and mortality in patients with COPD. Studies suggest that treatment with the long-acting muscarinic antagonist tiotropium and the long-acting β2-agonist olodaterol increases